|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.18 CNY | +4.44% |
|
+5.71% | -16.85% |
Guangxi Detianhou Investment Co., Ltd. entered into an agreement to acquire 15% stake in Beijing Cellonis Biotechnology Corp. from Nanning Baling Technology Co., Ltd. (SZSE:002592) for CNY 10 million on June 29, 2023. This has been approved in the 25th Meeting of the Company?s 6th Directorate held on June 29, 2023, and is subject to the Shareholders?
Approval. As of July 18, 2023, Nanning Baling Technology shareholders approved the transaction and received CNY 7 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.85% | 195M | |
| +9.91% | 4.21B | |
| +226.41% | 3.18B | |
| -24.08% | 3.15B | |
| +5.57% | 2.75B | |
| +33.25% | 2.24B | |
| -27.98% | 2.04B | |
| -20.08% | 1.26B | |
| -15.08% | 1.24B | |
| +50.22% | 1.13B |
NANNING BALING TECHNOLOGY CO., LTD. 
